360 High-Risk Vulnerability Immunization Tool V2.0 vs Ivanti Neurons for Vulnerability Knowledge Base: 2026 Comparison

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

Ivanti Neurons for Vulnerability Knowledge Base

Teams managing vulnerability programs across SMB to enterprise scale will get the most from Ivanti Neurons for Vulnerability Knowledge Base because its Vulnerability Risk Rating incorporates real-world exploit telemetry and APT activity data rather than relying on static CVSS scores alone. The platform ingests from over 100 independent sources and maps ransomware variants to specific CVEs, which directly strengthens ID.RA risk assessment and DE.AE threat characterization under NIST CSF 2.0. Skip this if you need downstream remediation tracking or patch management; Ivanti excels at the intelligence layer but stops short of orchestrating the fix.